deferiprone has been researched along with idebenone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, LS; Lynch, DR; Tsou, AY; Wilson, RB | 1 |
| Aracil, A; Artuch, R; Blanch, J; Capdevila, A; Jiménez, L; Mas, A; Montero, R; O'Callaghan, M; Pineda, M; Tondo, M; Velasco-Sánchez, D | 1 |
| Blanco-Sobero, L; Calap-Quintana, P; Gutiérrez, L; Llorens, JV; Martínez-Sebastián, MJ; Moltó, MD; Morales, MP; Soriano, S | 1 |
| Arpa, J; Domínguez-Melcón, FJ; Moreno-Yangüela, M; Oliva-Navarro, J; Prefasi, D; Rodríguez-de-Rivera, FJ; Sanz-Gallego, I | 1 |
| Jones, J; Martinez, S; Moraleda, JM; Quesada, MP; Rodríguez-Lozano, FJ | 1 |
| Ho, PW; Ho, SL; Lai, WH; Lau, YM; Lee, YK; Ng, KM; Siu, CW; Tse, HF | 1 |
| Arad, M; Cabantchik, I; Elincx-Benizri, S; Freimark, D; Glik, A; Hassin-Baer, S; Kozlova, E; Merkel, D | 1 |
1 review(s) available for deferiprone and idebenone
| Article | Year |
|---|---|
Pharmacotherapy for Friedreich ataxia.
Topics: Animals; Antioxidants; Deferiprone; Enzyme Inhibitors; Erythropoietin; Friedreich Ataxia; Histone Deacetylase Inhibitors; Humans; Iron Chelating Agents; Organophosphorus Compounds; Pyridones; Recombinant Proteins; Ubiquinone | 2009 |
2 trial(s) available for deferiprone and idebenone
| Article | Year |
|---|---|
Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
Topics: Adolescent; Adult; Deferiprone; Female; Friedreich Ataxia; Humans; Male; Middle Aged; Pilot Projects; Pyridones; Riboflavin; Severity of Illness Index; Treatment Outcome; Ubiquinone; Ultrasonography; Ventricular Dysfunction, Left; Young Adult | 2014 |
Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.
Topics: Adolescent; Adult; Antioxidants; Deferiprone; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Friedreich Ataxia; Humans; Iron Chelating Agents; Male; Pyridones; Quality of Life; Treatment Outcome; Ubiquinone; Young Adult | 2016 |
4 other study(ies) available for deferiprone and idebenone
| Article | Year |
|---|---|
Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
Topics: Adolescent; Adult; Antioxidants; Blood Cell Count; Brain Chemistry; Child; Deferiprone; Drug Therapy, Combination; Dysarthria; Female; Friedreich Ataxia; Gait Disorders, Neurologic; Heart Function Tests; Humans; Iron; Iron Chelating Agents; Magnetic Resonance Imaging; Male; Neurologic Examination; Oculomotor Muscles; Prospective Studies; Pyridones; Speech Disorders; Ubiquinone; Ultrasonography; Young Adult | 2011 |
Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Topics: Aconitate Hydratase; Animals; Antioxidants; Deferiprone; Disease Models, Animal; Drosophila; Frataxin; Friedreich Ataxia; Hyperoxia; Iron; Iron-Binding Proteins; Mitochondria; Mutation; Oxidative Stress; Phenotype; Pyridones; Ubiquinone | 2013 |
Novel aberrant genetic and epigenetic events in Friedreich's ataxia.
Topics: Antioxidants; Apoptosis; Azacitidine; Brain-Derived Neurotrophic Factor; Caspase 3; Cells, Cultured; Decitabine; Deferiprone; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Frataxin; Friedreich Ataxia; Gene Expression Profiling; Humans; Iron Chelating Agents; Iron-Binding Proteins; MicroRNAs; Neuregulin-1; Oxidative Stress; Periodontal Ligament; Pyridones; Superoxide Dismutase; Ubiquinone | 2015 |
Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
Topics: Antioxidants; Deferiprone; Drug Evaluation, Preclinical; Frataxin; Friedreich Ataxia; Gene Expression Regulation; Homeostasis; Humans; Induced Pluripotent Stem Cells; Iron; Iron Chelating Agents; Iron-Binding Proteins; Myocytes, Cardiac; Oxidative Stress; Pyridones; Reverse Transcriptase Polymerase Chain Reaction; RNA; Ubiquinone | 2016 |